ICUI Quote, Financials, Valuation and Earnings

InfuSystem Holdings, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of 6.19%. ICU Medical, Inc.'s return on equity of -0.36% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 18.2%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 63.78%. Given that InfuSystem Holdings, Inc. has higher upside potential than ICU Medical, Inc., analysts believe InfuSystem Holdings, Inc. is more attractive than ICU Medical, Inc..

ICU Medical, Inc. has a beta of 0.799, which suggesting that the stock is 20.087% less volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. ICU Medical, Inc.'s net income of -$3.4M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while InfuSystem Holdings, Inc.'s PE ratio is 33.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.62x versus 1.30x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Merit Medical Systems, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of 7.22%. ICU Medical, Inc.'s return on equity of -0.36% beat Merit Medical Systems, Inc.'s return on equity of 8.28%.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 18.2%. On the other hand Merit Medical Systems, Inc. has an analysts' consensus of $103.60 which suggests that it could grow by 19.94%. Given that Merit Medical Systems, Inc. has higher upside potential than ICU Medical, Inc., analysts believe Merit Medical Systems, Inc. is more attractive than ICU Medical, Inc..

ICU Medical, Inc. has a beta of 0.799, which suggesting that the stock is 20.087% less volatile than S&P 500. In comparison Merit Medical Systems, Inc. has a beta of 0.617, suggesting its less volatile than the S&P 500 by 38.251%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Merit Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. Merit Medical Systems, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than Merit Medical Systems, Inc. quarterly revenues of $384.3M. ICU Medical, Inc.'s net income of -$3.4M is lower than Merit Medical Systems, Inc.'s net income of $27.8M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while Merit Medical Systems, Inc.'s PE ratio is 44.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.62x versus 3.55x for Merit Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

TriSalus Life Sciences, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of -93.47%. ICU Medical, Inc.'s return on equity of -0.36% beat TriSalus Life Sciences, Inc.'s return on equity of --.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 18.2%. On the other hand TriSalus Life Sciences, Inc. has an analysts' consensus of $11.50 which suggests that it could grow by 98.28%. Given that TriSalus Life Sciences, Inc. has higher upside potential than ICU Medical, Inc., analysts believe TriSalus Life Sciences, Inc. is more attractive than ICU Medical, Inc..

ICU Medical, Inc. has a beta of 0.799, which suggesting that the stock is 20.087% less volatile than S&P 500. In comparison TriSalus Life Sciences, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TriSalus Life Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. TriSalus Life Sciences, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than TriSalus Life Sciences, Inc. quarterly revenues of $11.6M. ICU Medical, Inc.'s net income of -$3.4M is higher than TriSalus Life Sciences, Inc.'s net income of -$10.8M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while TriSalus Life Sciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.62x versus 4.76x for TriSalus Life Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of 3.93%. ICU Medical, Inc.'s return on equity of -0.36% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 18.2%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 119.94%. Given that Xtant Medical Holdings, Inc. has higher upside potential than ICU Medical, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than ICU Medical, Inc..

ICU Medical, Inc. has a beta of 0.799, which suggesting that the stock is 20.087% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. ICU Medical, Inc.'s net income of -$3.4M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 66.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.62x versus 0.74x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.